1-1-diphenyl-2-picrylhydrazyl and Renal-Insufficiency--Chronic

1-1-diphenyl-2-picrylhydrazyl has been researched along with Renal-Insufficiency--Chronic* in 2 studies

Reviews

1 review(s) available for 1-1-diphenyl-2-picrylhydrazyl and Renal-Insufficiency--Chronic

ArticleYear
Therapeutics for Inflammatory-Related Diseases Based on Plasmon-Activated Water: A Review.
    International journal of molecular sciences, 2018, May-28, Volume: 19, Issue:6

    It is recognized that the properties of liquid water can be markedly different from those of bulk one when it is in contact with hydrophobic surfaces or is confined in nano-environments. Because our knowledge regarding water structure on the molecular level of dynamic equilibrium within a picosecond time scale is far from completeness all of water's conventionally known properties are based on inert "bulk liquid water" with a tetrahedral hydrogen-bonded structure. Actually, the strength of water's hydrogen bonds (HBs) decides its properties and activities. In this review, an innovative idea on preparation of metastable plasmon-activated water (PAW) with intrinsically reduced HBs, by letting deionized (DI) water flow through gold-supported nanoparticles (AuNPs) under resonant illumination at room temperature, is reported. Compared to DI water, the created stable PAW can scavenge free hydroxyl and 2,2-diphenyl-1-picrylhydrazyl radicals and effectively reduce NO release from lipopolysaccharide-induced inflammatory cells. Moreover, PAW can dramatically induce a major antioxidative

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biphenyl Compounds; Disease Models, Animal; Fibroblasts; Gene Expression; Gold; Humans; Hydrogen Bonding; Lipopolysaccharides; Lung Neoplasms; Nanoparticles; NF-E2-Related Factor 2; Nitric Oxide; Picrates; Renal Insufficiency, Chronic; Sleep Deprivation; Surface Plasmon Resonance; Water

2018

Other Studies

1 other study(ies) available for 1-1-diphenyl-2-picrylhydrazyl and Renal-Insufficiency--Chronic

ArticleYear
Vascular effects of advanced glycation end-products: content of immunohistochemically detected AGEs in radial artery samples as a predictor for arterial calcification and cardiovascular risk in asymptomatic patients with chronic kidney disease.
    Disease markers, 2015, Volume: 2015

    Our aim was to determine whether vascular deposition of advanced glycation end-products (AGEs) is associated with arterial calcification and cardiovascular mortality in chronic kidney disease (CKD) patients and to assess the relationships between vascular content of AGEs and selected clinical and biochemical parameters.. The study comprised 54 CKD patients (33 hemodialyzed, 21 predialyzed). Examined parameters included BMI, incidence of diabetes, plasma fasting glucose, AGEs, soluble receptor for AGEs and 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging, serum C-reactive protein (hsCRP), plasminogen activator inhibitor-1 (PAI-1), and fetuin-A. Fragments of radial artery obtained during creation of hemodialysis access were stained for calcifications using alizarin red. AGEs deposits were identified immunohistochemically and their relative content was quantified.. Vascular content of AGEs was positively correlated with BMI, hsCRP, fetuin-A, PAI-1, and DPPH scavenging in simple regression; only fetuin-A was an independent predictor in multiple regression. There was a significant positive trend in the intensity of AGEs immunostaining among patients with grades 1, 2, and 3 calcifications. AGEs immunostaining intensity predicted 3-year cardiovascular mortality irrespective of patient's age.. The present study demonstrates an involvement of AGEs in the development of medial arterial calcification and the impact of arterial AGE deposition on cardiovascular mortality in CKD patients.

    Topics: Aged; alpha-2-HS-Glycoprotein; Biomarkers; Biphenyl Compounds; C-Reactive Protein; Calcinosis; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Humans; Male; Middle Aged; Picrates; Plasminogen Activator Inhibitor 1; Radial Artery; Renal Insufficiency, Chronic

2015